Jacobs Levy Equity Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.7M Buy
350,605
+162,094
+86% +$4.95M 0.04% 293
2025
Q1
$5.08M Buy
188,511
+59,535
+46% +$1.61M 0.02% 454
2024
Q4
$4.63M Buy
128,976
+18,490
+17% +$664K 0.02% 449
2024
Q3
$4.19M Sell
110,486
-27,260
-20% -$1.03M 0.02% 470
2024
Q2
$6.23M Buy
137,746
+26,254
+24% +$1.19M 0.03% 411
2024
Q1
$5.41M Buy
111,492
+2,820
+3% +$137K 0.02% 415
2023
Q4
$5.82M Buy
108,672
+18,013
+20% +$965K 0.03% 400
2023
Q3
$5.31M Buy
90,659
+2,168
+2% +$127K 0.03% 368
2023
Q2
$5.58M Buy
88,491
+12,701
+17% +$801K 0.03% 370
2023
Q1
$4.77M Sell
75,790
-48,017
-39% -$3.02M 0.03% 409
2022
Q4
$6.59M Buy
123,807
+4,091
+3% +$218K 0.04% 351
2022
Q3
$6.71M Sell
119,716
-9,025
-7% -$506K 0.05% 333
2022
Q2
$9.32M Buy
128,741
+21,264
+20% +$1.54M 0.07% 291
2022
Q1
$8.54M Buy
107,477
+2,180
+2% +$173K 0.06% 325
2021
Q4
$10.7M Buy
105,297
+61,154
+139% +$6.19M 0.07% 291
2021
Q3
$4.07M Buy
44,143
+3,273
+8% +$302K 0.03% 477
2021
Q2
$4.19M Sell
40,870
-2,039
-5% -$209K 0.03% 471
2021
Q1
$4.19M Sell
42,909
-24,725
-37% -$2.41M 0.03% 450
2020
Q4
$5.22M Sell
67,634
-23,442
-26% -$1.81M 0.05% 388
2020
Q3
$6.71M Buy
91,076
+1,027
+1% +$75.6K 0.07% 285
2020
Q2
$6.61M Sell
90,049
-34,652
-28% -$2.54M 0.07% 285
2020
Q1
$7.2M Buy
124,701
+44,692
+56% +$2.58M 0.09% 234
2019
Q4
$6.29M Buy
+80,009
New +$6.29M 0.06% 331
2019
Q2
Sell
-71,054
Closed -$5.96M 1031
2019
Q1
$5.96M Buy
71,054
+25,610
+56% +$2.15M 0.09% 300
2018
Q4
$5.35M Sell
45,444
-710
-2% -$83.6K 0.09% 241
2018
Q3
$5.56M Buy
46,154
+10,059
+28% +$1.21M 0.08% 294
2018
Q2
$4.16M Buy
+36,095
New +$4.16M 0.07% 345
2017
Q2
Sell
-5,740
Closed -$331K 1020
2017
Q1
$331K Buy
5,740
+100
+2% +$5.77K 0.01% 712
2016
Q4
$345K Buy
+5,640
New +$345K 0.01% 742
2016
Q1
Sell
-4,700
Closed -$300K 1185
2015
Q4
$300K Hold
4,700
0.01% 648
2015
Q3
$315K Buy
+4,700
New +$315K 0.01% 643
2014
Q3
Sell
-6,280
Closed -$245K 912
2014
Q2
$245K Buy
6,280
+600
+11% +$23.4K ﹤0.01% 739
2014
Q1
$214K Buy
+5,680
New +$214K ﹤0.01% 812